Compare ENLV & SCPQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENLV | SCPQ |
|---|---|---|
| Founded | 2005 | 2025 |
| Country | Israel | United States |
| Employees | N/A | 2 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.0M | 136.7M |
| IPO Year | 2014 | N/A |
| Metric | ENLV | SCPQ |
|---|---|---|
| Price | $4.20 | $10.00 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 280.7K | 7.4K |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.43 | $9.86 |
| 52 Week High | $7.64 | $10.04 |
| Indicator | ENLV | SCPQ |
|---|---|---|
| Relative Strength Index (RSI) | 57.84 | 60.10 |
| Support Level | $0.79 | $9.89 |
| Resistance Level | $7.64 | N/A |
| Average True Range (ATR) | 0.59 | 0.01 |
| MACD | -0.09 | 0.00 |
| Stochastic Oscillator | 50.64 | 50.00 |
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
Social Commerce Partners Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses.